Search results
New Oral Weight Loss Drugs: Where Are We and What's Next?
Medscape· 2 days agoOne particularly...-101 is a bitter taste receptor (TAS2R) that mediates hunger, whereas the GLP-1...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via AOL· 1 day agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into ...
3 Dow Stocks That Are No-Brainer Buys in June
Motley Fool via Yahoo Finance· 3 hours agoMay was an eventful month for Salesforce, and not in a good way. The CRM software provider's sales guidance missed the mark, based on Wall Street's...
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to...
Insider Monkey via Yahoo Finance· 17 hours agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Stakeholders question federal drug discount program at Michigan House Insurance hearing
Michigan Advance via Yahoo News· 17 hours agoRepresentatives of the pharmaceutical industry and various health care networks sparred over a...
Pharma, pharmacies debate drug price reform in Michigan House committee
The Center Square· 18 hours agoHouse Bill 5350, introduced by Rep. Alabas Farhat, D-Dearborn, would require drug manufacturers to...
Antitrust Investigation Targets Major Pharma Companies in Italy
PYMNTS.com· 18 hours agoItaly’s antitrust agency, the Italian Competition Authority (AGCM), has launched an investigation...
3 Dow Stocks That Are No-Brainer Buys in June
The Motley Fool via AOL· 3 hours agoMay was an eventful month for Salesforce, and not in a good way. The CRM software provider's sales guidance missed the mark, based on Wall Street's...
Bipartisan Efforts To Legislate Pharmaceutical Patent Reform Heat Up
Forbes· 4 days agoThe steep prices of brand-name drugs in the United States can in part owe to possibly...
European pharma regulation changes signal tumult and transformation
Pharmaceutical Technology via Yahoo Finance· 1 day agoMidway through the discussion, the panellists...The two main tracks of regulation on everyone’s...